Synopsis of recent research by authors named "Daniel Fort"
- Daniel Fort's recent research focuses on multiple areas spanning hepatocellular carcinoma (HCC) treatment outcomes, urgent carotid interventions, and implications of diabetes care, highlighting critical biomarkers and risk factors in patient populations.
- Key findings include the identification of alpha-fetoprotein and its variants as important biomarkers for stratifying HCC treatment responses and progression risk, as well as the significance of frailty scores in predicting outcomes for acute stroke patients undergoing carotid interventions.
- Additionally, Fort's studies underscore the healthcare burden of influenza in diabetic patients and emphasize the need for guideline adherence in chronic kidney disease screening and treatment for those with type 2 diabetes, reflecting his commitment to improving patient care through evidence-based research.
